US2012046734A1PendingUtilityA1
Medical devices and methods of making the same
Individually held — no corporate assignee on recordPriority: Sep 15, 2006Filed: Oct 28, 2011Published: Feb 23, 2012
Est. expirySep 15, 2026(~0.2 yrs left)· nominal 20-yr term from priority
Inventors:Timothy S. Girton
A61L 31/148A61L 27/56A61L 2300/00A61L 31/16A61L 31/146A61L 2400/08A61L 33/007A61F 2/07A61L 2/235A61F 2250/0023A61F 2/82
47
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Medical devices, such as endoprostheses, and related methods are disclosed.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . An endoprosthesis, comprising:
a generally tubular member comprising a bioerodible material selected from the group consisting of bioerodible metals, bioerodible metal alloys, and combinations thereof, the generally tubular member having a first region defining an interior surface of the generally tubular member and a second region defining an exterior surface of the generally tubular member, wherein the first region has a first pore density, and the second region has a second pore density that is higher than the first pore density.
2 . The endoprosthesis of claim 1 , further comprising a polymer.
3 . The endoprosthesis of claim 2 , wherein the polymer is supported by the generally tubular member.
4 . The endoprosthesis of claim 2 , wherein the polymer is disposed within the first and/or second groups of said pores of the generally tubular member.
5 . The endoprosthesis of claim 2 , comprising a composite including a therapeutic agent and the polymer.
6 . The endoprosthesis of claim 1 , wherein the generally tubular member includes an exterior surface and an interior surface defining the lumen, and the first region of the at least one component defines at least a portion of the interior surface.
7 . The endoprosthesis of claim 6 , wherein the second region of the at least one component defines at least a portion of the exterior surface.
8 . The endoprosthesis of claim 1 , wherein the first region has a first average pore volume and the second region has a second average pore volume that is greater than the first pore density.
9 . The endoprosthesis of claim 1 , wherein the first region and the second region each comprise non-interconnected pores.
10 . An endoprosthesis, comprising:
a generally tubular member comprising a bioerodible material selected from the group consisting of bioerodible metals, bioerodible metal alloys, and combinations thereof, the generally tubular member having at least one pore; and a polymer disposed within the at least one pore.
11 . The endoprosthesis of claim 10 , wherein the polymer is bioerodible.
12 . The endoprosthesis of claim 10 , comprising a composite including the polymer and the therapeutic agent.
13 . The endoprosthesis of claim 10 , wherein the generally tubular member comprises a plurality of non-interconnected pores.
14 . The endoprosthesis of claim 13 , wherein the generally tubular member comprises at least a first porous region and a second porous region.
15 . The endoprosthesis of claim 14 , the non-interconnected closed pores in the first porous region have a first average volume and the non-interconnected closed pores in the second porous region having a second average volume that is greater than the first average volume.
16 . The endoprosthesis of claim 14 , the non-interconnected closed pores in the first porous region have a first pore density and the non-interconnected closed pores in the second porous region having a second pore density that is greater than the first pore density.
17 . An endoprosthesis, comprising:
a generally tubular member having a lumen and including at least one component selected from the group consisting of struts, bands, and combinations thereof, wherein the at least one component comprises a reservoir surrounded by a matrix having at least one pore and comprising a bioerodible material selected from the group consisting of bioerodible metals, bioerodible metal alloys, and combinations thereof.
18 . The endoprosthesis of claim 17 , wherein the reservoir contains a therapeutic agent.
19 . The endoprosthesis of claim 17 , wherein the reservoir comprises a plurality of non-interconnected pores.
20 . The endoprosthesis of claim 19 , wherein the reservoir comprises at least a first porous region and a second porous region having different average pore densities or different average pore volumes.Join the waitlist — get patent alerts
Track US2012046734A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.